Infectious Disease drug pipeline

Antibacterial, antiviral, antifungal, and antiparasitic therapeutics including HIV, hepatitis, TB, COVID.

Recent approvals (last 30 days)

No approvals in this window.

Upcoming PDUFA dates (next 6 months)

No upcoming decisions in this window.

Top sponsors

1. · 237 drugs
2. GlaxoSmithKline · 170 drugs
3. Pfizer · 87 drugs
4. Merck Sharp & Dohme LLC · 84 drugs
5. Sanofi Pasteur, a Sanofi Company · 58 drugs
6. ViiV Healthcare · 55 drugs
7. National Institute of Allergy and Infectious Diseases (NIAID) · 44 drugs
8. London School of Hygiene and Tropical Medicine · 38 drugs
9. National Taiwan University Hospital · 30 drugs
10. University of Oxford · 30 drugs

Key drug classes

• Live attenuated vaccine · 97
• vaccine · 66
• Inactivated viral vaccine · 63
• Conjugate vaccine · 57
• Inactivated influenza vaccine · 55
• mRNA vaccine · 41
• Combination vaccine · 41
• Macrolide antibiotic · 35
• HIV protease inhibitor · 35
• Fluoroquinolone antibiotic · 34
• Antimalarial combination · 33
• Vaccine · 32
• Integrase strand transfer inhibitor (INSTI) · 31
• Recombinant protein vaccine · 28
• Beta-lactam antibiotic with beta-lactamase inhibitor · 26

Major diseases in this area

• hiv
• hepatitis c

Subscribe

Get infectious disease approvals + PDUFA dates in your RSS reader:

• Infectious Disease RSS feed · Atom · JSON

Other therapeutic areas